• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Virus Evol . The early SARS-CoV-2 epidemic in Senegal was driven by the local emergence of B.1.416 and the introduction of B.1.1.420 from Europe

tetano

Editor, Senior Moderator
Virus Evol


. 2022 Mar 21;8(1):veac025.
doi: 10.1093/ve/veac025. eCollection 2022.
The early SARS-CoV-2 epidemic in Senegal was driven by the local emergence of B.1.416 and the introduction of B.1.1.420 from Europe


Lester J Perez[SUP] 1 [/SUP], Gregory S Orf[SUP] 1 [/SUP], Michael G Berg[SUP] 1 [/SUP], Mary A Rodgers[SUP] 1 [/SUP], Todd V Meyer[SUP] 1 [/SUP], Aurash Mohaimani[SUP] 1 [/SUP], Ana Olivo[SUP] 1 [/SUP], Barbara Harris[SUP] 1 [/SUP], Illya Mowerman[SUP] 1 [/SUP], Abdou Padane[SUP] 2 [/SUP], Agbogbenkou Tevi Dela-Del Lawson[SUP] 2 [/SUP], Aminata Mboup[SUP] 2 [/SUP], Moustapha Mbow[SUP] 2 [/SUP], Nafissatou Leye[SUP] 2 [/SUP], Ndeye Coumba Touré-Kane[SUP] 2 [/SUP], Ambroise D Ahouidi[SUP] 2 [/SUP], Gavin A Cloherty[SUP] 1 [/SUP], Souleymane Mboup[SUP] 2 [/SUP]



Affiliations

Abstract

Molecular surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is growing in west Africa, especially in the Republic of Senegal. Here, we present a molecular epidemiology study of the early waves of SARS-CoV-2 infections in this country based on Bayesian phylogeographic approaches. Whereas the first wave in mid-2020 was characterized by a significant diversification of lineages and predominance of B.1.416, the second wave in late 2020 was composed primarily of B.1.1.420. Our results indicate that B.1.416 originated in Senegal and was exported mainly to Europe. In contrast, B.1.1.420 was introduced from Italy, gained fitness in Senegal, and then spread worldwide. Since both B.1.416 and B.1.1.420 lineages carry several positive selected mutations in the spike and nucleocapsid genes, each of which may explain their local dominance, their mutation profiles should be carefully monitored. As the pandemic continues to evolve, molecular surveillance in all regions of Africa will play a key role in stemming its spread.

Keywords: Bayesian inference of phylogeny; SARS-CoV-2; Senegal; phylogeography; positive selection analysis; variants of interest; viral surveillance.
 
Back
Top Bottom